Higher Use of Any Rx Medications Seen Years Before IBD Diagnosis

2024-01-19
drugs
临床结果
FRIDAY, Jan. 19, 2024 -- Individuals with inflammatory bowel disease (IBD) universally show increased prescription medication use years before diagnosis, according to a study published in the December issue of the American Journal of Gastroenterology.
Linéa Bonfils, M.D., from Aalborg University in Copenhagen, Denmark, and colleagues compared use of any prescription medication between individuals with and without IBD in a 10-year period preceding diagnosis. The analysis included 29,219 individuals diagnosed with IBD in Denmark between 2005 and 2018 and 292,190 matched, IBD-free individuals.
The researchers found that the IBD group had a universally increased use of any prescription medications versus the matched controls before IBD diagnosis. For 12 of 14 Anatomical Therapeutic Chemical main groups of medication, the proportion of users was 1.1-fold to 1.8-fold higher in the IBD population 10 years before diagnosis. Results were consistent across age, sex, and IBD subtypes, but were most pronounced for Crohn disease (CD). The IBD population had a steep increase in medication use for several organ systems two years before diagnosis. The CD population showed 2.7 times more users of immunosuppressants, 2.3 times more users of antianemic preparations, and 1.9 times more users of both analgesics and psycholeptics than the matched controls 10 years before diagnosis.
"Our findings demonstrate universally increased medication use years before IBD, especially CD, diagnosis and indicates multiorgan involvement in IBD," the authors write.
One author disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Posted January 2024
More news resources
FDA Medwatch Drug Alerts
Daily MedNews
News for Health Professionals
New Drug Approvals
New Drug Applications
Drug Shortages
Clinical Trial Results
Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
机构
适应症
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。